CYTOTECH ApS: Financial statements 2014
CVR: 19898504
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
CYTOTECH ApS (CVR 19898504) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 311,591 and a net result of DKK -26,368 compared with DKK 2,850 the year before. That is an increase of 26.2% compared with the year before. Equity in the 2014 report amounted to DKK 14,297. The solvency ratio was 4%.
- Gross Profit
- DKK 311,591
- Profit/Loss
- DKK -26,368
- Equity
- DKK 14,297
- Total Assets
- DKK 353,819
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 312 t. | -26 t. | 14 t. | - |
| 2013 | - | 247 t. | 3 t. | 41 t. | - |
| 2012 | - | 153 t. | - | - | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
CYTOTECH ApS has published its annual report for 2013. Gross profit came to DKK 246,969, and the net result was DKK 2,850.
As of January 2, 2014, AAEN & CO. STATSAUTORISEREDE REVISORER P/S has been appointed auditor of CYTOTECH ApS.
As of January 2, 2014, DANSK REVISION HILLERØD GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of CYTOTECH ApS.
About CYTOTECH ApS
CYTOTECH ApS is a Danish company of the type Anpartsselskab based in Hellebæk, founded in 1997. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Patrick van Dijk Munch-Fals. The company is owned by Patrick van Dijk Munch-Fals. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 196,108 and a net result of DKK -70,656 compared with DKK -113,059 the year before. Equity in the 2025 report amounted to DKK -27,461.